A phase 1b, open-label, multicenter study of xaluritamig in patients with biochemical recurrence of prostate cancer after definitive therapy Meeting Abstract
| Authors: | Tran, B.; Courtney, K. D.; Sokolova, A.; Horvath, L.; Danila, D. C.; Hawley, J. E.; Pook, D. W.; Brown, L. C.; Whang, Y. E.; Buetikofer, S.; Wang, K.; Zorko, N. |
| Abstract Title: | A phase 1b, open-label, multicenter study of xaluritamig in patients with biochemical recurrence of prostate cancer after definitive therapy |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454809900024 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.TPS435 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS435 -- Source: Wos |
